Cardiovascular Disease (CVD) Completed Phase 4 Trials for Rilpivirine (DB08864)

Also known as: Cardio Vascular Disease / Cardiovascular Diseases / Cardio-vascular Disease / Cardiovascular Disease / Cardio-vascular Diseases / Diseases, Cardiovascular / Cardiovascular disease, unspecified / Heart diseases / Cardiovascular disorder / Cardiovascular disorder NOS / Disorder cardiovascular (NOS) / Cardiovascular disorder (NOS)

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01585038Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative StressTreatment